All Stories

  1. In vitro safety and in vivo proof of concept of bacterial lysate-loaded inhalable locust bean gum microparticles aimed at respiratory infection prevention
  2. Localized gold nanoparticles–mediated photothermal therapy for head and neck cancer: in vivo proof-of-concept
  3. Correction: Ribeiro et al. Liposomal Formulations of a New Zinc(II) Complex Exhibiting High Therapeutic Potential in a Murine Colon Cancer Model. Int. J. Mol. Sci. 2022, 23, 6728
  4. Organic nanoplatforms for metallodrugs delivery: Current advances in colorectal cancer
  5. Targeting Triple-Negative Breast Cancer: A Special Focus on Phototherapy and Nanomaterials
  6. Liposomal formulations of novel metal-based complexes exhibiting high antitumor activity against melanoma
  7. Valorization of Thyme Combined with Phytocannabinoids as Anti-Inflammatory Agents for Skin Diseases
  8. Towards a Less Invasive Treatment for Head and Neck Cancer: Initial Evaluation of Gold Nanoparticle-Mediated Photothermal Therapy
  9. Gold nanoparticle-mediated photothermal therapy: Expanding the frontiers of cancer treatment and theragnostics
  10. Metabolism-targeted therapy in NSCLC – A new theranostics inhalation approach using lactate functionalized and selenium-chrysin loaded nanoparticles (SeChry@PUREG4-LA24)
  11. Locust bean gum (LBG) – A potential excipient for inhalation purposes: Excipient characterisation and in vitro and in vivo toxicological evaluation
  12. Phytosomal delivery enhances bioactivity of Hylocereus costaricensis phenolic extract
  13. Novel 8-Hydroxyquinoline-Derived V(IV)O, Ni(II), and Fe(III) Complexes: Synthesis, Characterization, and In Vitro Cytotoxicity Against Tumor Cells
  14. Liposomal nanoformulations of novel copper-based complexes exhibiting antimelanoma activity – In vitro and in vivo validation
  15. A step forward on the in vitro and in vivo validation of rifabutin-loaded liposomes for the management of highly virulent MRSA infections
  16. Correction: Oliveira et al. Discovery of a Necroptosis Inhibitor Improving Dopaminergic Neuronal Loss after MPTP Exposure in Mice. Int. J. Mol. Sci. 2021, 22, 5289
  17. Combination of gold nanoparticles with near-infrared light as an alternative approach for melanoma management
  18. Exploring the Biological Activity of Phytocannabinoid Formulations for Skin Health Care: A Special Focus on Molecular Pathways
  19. Liposomal Formulation of an Organogold Complex Enhancing Its Activity as Antimelanoma Agent—In Vitro and In Vivo Studies
  20. In Vivo Measurements of Murine Melanoma's Complex Permittivity Between 500 MHz and 8.5 GHz
  21. Gold nanoparticles for photothermal therapy – Influence of experimental conditions on the properties of resulting AuNPs
  22. 3D-printed aerogels as theranostic implants monitored by fluorescence bioimaging
  23. Combining Phototherapy and Gold-Based Nanomaterials: A Breakthrough in Basal Cell Carcinoma Treatment
  24. Rifabutin: a repurposed antibiotic with high potential against planktonic and biofilm staphylococcal clinical isolates
  25. Targeting superficial cancers with gold nanoparticles: a review of current research
  26. Selenium Nanoparticles Synergize with a KRAS Nanovaccine against Breast Cancer
  27. Enhanced Cytotoxicity against a Pancreatic Cancer Cell Line Combining Radiation and Gold Nanoparticles
  28. Role of ionic liquids in ibuprofen-based eutectic systems: Aqueous solubility, permeability, human cytotoxicity, hemolytic activity and anti-inflammatory activity
  29. Necroptosis induced by ruthenium (II) complexes as mitochondrial disruptors
  30. An alternative hybrid lipid nanosystem combining cytotoxic and magnetic properties as a tool to potentiate antitumor effect of 5-fluorouracil
  31. A Step Forward for the Treatment of Localized Prostate Cancer Using Gold Nanoparticles Combined with Laser Irradiation
  32. Liposomal Rifabutin—A Promising Antibiotic Repurposing Strategy against Methicillin-Resistant Staphylococcus aureus Infections
  33. Liposomal Rifabutin – A Promising Antibiotic Repurposing Strategy against Methicillin-Resistant <em>Staphylococcus aureus </em>Infections
  34. Antimicrobial activity of prophage endolysins against critical Enterobacteriaceae antibiotic-resistant bacteria
  35. Rational approach to design gold nanoparticles for photothermal therapy: the effect of gold salt on physicochemical, optical and biological properties
  36. Structural Optimization of Antimycobacterial Azaaurones Towards Improved Solubility and Metabolic Stability
  37. The current role of cannabis and cannabinoids in health: A comprehensive review of their therapeutic potential
  38. Respirable konjac glucomannan microparticles as antitubercular drug carriers: Effects of in vitro and in vivo interactions
  39. Panobinostat-loaded folate targeted liposomes as a promising drug delivery system for treatment of canine B-cell lymphoma
  40. Breast Cancer Brain Metastases: Implementation and Characterization of a Mouse Model Relying on Malignant Cells Inoculation in the Carotid Artery
  41. miR‐21‐5p promotes NASH‐related hepatocarcinogenesis
  42. Cu(II) and Zn(II) Complexes of New 8-Hydroxyquinoline Schiff Bases: Investigating Their Structure, Solution Speciation, and Anticancer Potential
  43. A step forward on the in vitro and in vivo assessment of a novel nanomedicine against melanoma
  44. Experimental Murine Models for Colorectal Cancer Research
  45. Safety of Gold Nanoparticles: From In Vitro to In Vivo Testing Array Checklist
  46. Pluronic® F127 Hydrogel Containing Silver Nanoparticles in Skin Burn Regeneration: An Experimental Approach from Fundamental to Translational Research
  47. Advancing Medicine with Lipid-Based Nanosystems—The Successful Case of Liposomes
  48. Liposomal Delivery of Saquinavir to Macrophages Overcomes Cathepsin Blockade by Mycobacterium tuberculosis and Helps Control the Phagosomal Replicative Niches
  49. Preclinical validation of a new hybrid molecule loaded in liposomes for melanoma management
  50. Challenges in delivery of plant actives
  51. Current Insights and Progress in the Clinical Management of Head and Neck Cancer
  52. Metal Coordination and Biological Screening of a Schiff Base Derived from 8-Hydroxyquinoline and Benzothiazole
  53. 3D-MSCs A151 ODN-loaded exosomes are immunomodulatory and reveal a proteomic cargo that sustains wound resolution
  54. Nanoformulation of Seaweed Eisenia bicyclis in Albumin Nanoparticles Targeting Cardiovascular Diseases: In Vitro and In Vivo Evaluation
  55. Melanoma Management: From Epidemiology to Treatment and Latest Advances
  56. Liposomal Delivery of Newly Identified Prophage Lysins in a Pseudomonas aeruginosa Model
  57. How to Treat Melanoma? The Current Status of Innovative Nanotechnological Strategies and the Role of Minimally Invasive Approaches like PTT and PDT
  58. Human Cytotoxicity, Hemolytic Activity, Anti-Inflammatory Activity and Aqueous Solubility of Ibuprofen-Based Ionic Liquids
  59. Biological Thermal Performance of Organic and Inorganic Aerogels as Patches for Photothermal Therapy
  60. New iron(III) anti-cancer aminobisphenolate/phenanthroline complexes: Enhancing their therapeutic potential using nanoliposomes
  61. Liposomal Formulations of a New Zinc(II) Complex Exhibiting High Therapeutic Potential in a Murine Colon Cancer Model
  62. Targeted liposomal doxorubicin/ceramides combinations: The importance to assess the nature of drug interaction beyond bulk tumor cells
  63. Liposomes as Tools to Improve Therapeutic Enzyme Performance
  64. The Role of Rosmarinic Acid on the Bioproduction of Gold Nanoparticles as Part of a Photothermal Approach for Breast Cancer Treatment
  65. A Comprehensive Updated Review on Magnetic Nanoparticles in Diagnostics
  66. The Challenging Melanoma Landscape: From Early Drug Discovery to Clinical Approval
  67. Highly Specific Blood-Brain Barrier Transmigrating Single-Domain Antibodies Selected by an In Vivo Phage Display Screening
  68. Sulfur Analogues of Tyrosine in the Development of Triazene Hybrid Compounds: A New Strategy against Melanoma
  69. Microencapsulated Chitosan-Based Nanocapsules: A New Platform for Pulmonary Gene Delivery
  70. miR-335 Targets LRRK2 and Mitigates Inflammation in Parkinson’s Disease
  71. Discovery of a Necroptosis Inhibitor Improving Dopaminergic Neuronal Loss after MPTP Exposure in Mice
  72. A Newfangled Collagenase Inhibitor Topical Formulation Based on Ethosomes with Sambucus nigra L. Extract
  73. Development of a Topical Insulin Polymeric Nanoformulation for Skin Burn Regeneration: An Experimental Approach
  74. Liposomes as Antibiotic Delivery Systems: A Promising Nanotechnological Strategy against Antimicrobial Resistance
  75. GMP-grade nanoparticle targeted to nucleolin downregulates tumor molecular signature, blocking growth and invasion, at low systemic exposure
  76. Therapeutic potential of a copper complex loaded in pH-sensitive long circulating liposomes for colon cancer management
  77. Proof-of-Concept Study of Multifunctional Hybrid Nanoparticle System Combined with NIR Laser Irradiation for the Treatment of Melanoma
  78. Gold-Based Nanoplataform for the Treatment of Anaplastic Thyroid Carcinoma: A Step Forward
  79. Ecotoxicity and Hemolytic Activity of Fluorinated Ionic Liquids
  80. Liposomes as a Nanoplatform to Improve the Delivery of Antibiotics into Staphylococcus aureus Biofilms
  81. Nanomedicines in the treatment of colon cancer: a focus on metallodrugs
  82. Advances in nanotechnology-related strategies against melanoma
  83. RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver disease
  84. Recent Advances in Ionic Liquids and Nanotechnology for Drug Delivery
  85. A Step Forward in Breast Cancer Research: From a Natural-Like Experimental Model to a Preliminary Photothermal Approach
  86. Further Evidence of Possible Therapeutic Uses of Sambucus nigra L. Extracts by the Assessment of the In Vitro and In Vivo Anti-Inflammatory Properties of Its PLGA and PCL-Based Nanoformulations
  87. Synchronous insight of in vitro and in vivo biological activities of Sambucus nigra L. extracts for industrial uses
  88. Preliminary Assays towards Melanoma Cells Using Phototherapy with Gold-Based Nanomaterials
  89. mIR-21 is increased in patients with NASH-associated HCC and contributes to hepatocarcinogenesis in mice with NAFLD
  90. The role of RIPK3 in non-alcoholic fatty liver disease: a multi-omics perspective
  91. Lipid-based nanosystems for targeting bone implant-associated infections: current approaches and future endeavors
  92. How Can Biomolecules Improve Mucoadhesion of Oral Insulin? A Comprehensive Insight using Ex-Vivo, In Silico, and In Vivo Models
  93. A Novel Hybrid Nanosystem Integrating Cytotoxic and Magnetic Properties as a Tool to Potentiate Melanoma Therapy
  94. The Aquaporin-3-Inhibiting Potential of Polyoxotungstates
  95. If you cannot beat them, join them: Exploring the fruits of the invasive species Carpobrotus edulis (L.) N.E. Br as a source of bioactive products
  96. Inhalable locust bean gum microparticles co-associating isoniazid and rifabutin: Therapeutic assessment in a murine model of tuberculosis infection
  97. Development and Mechanistic Insight into the Enhanced Cytotoxic Potential of Parvifloron D Albumin Nanoparticles in EGFR-Overexpressing Pancreatic Cancer Cells
  98. Ablation of RIP3 protects from dopaminergic neurodegeneration in experimental Parkinson’s disease
  99. Emergent Nanotechnological Strategies for Systemic Chemotherapy against Melanoma
  100. Pharmaceutical Benefits of Fluticasone Propionate Association to Delivery Systems: In Vitro and In Vivo Evaluation
  101. 11th International Meeting of the Portuguese Society for Stem Cells and Cell Therapies
  102. Abstracts of the 55th Congress of the European Societies of Toxicology (EUROTOX 2019) TOXICOLOGY SCIENCE PROVIDING SOLUTIONS
  103. Demonstrating the Safety of Nanoparticles with Persimmon Extract
  104. FRI-278-RIP3-dependent signalling exerts divergent effects on liver steatosis and carcinogenesis in experimental non-alcholic fatty liver disease
  105. Copper Complex Nanoformulations Featuring Highly Promising Therapeutic Potential in Murine Melanoma Models
  106. New Hyaluronic Acid Particles for Longer-Lasting Osteoarthritis Relief
  107. The Secretome Derived From 3D-Cultured Umbilical Cord Tissue MSCs Counteracts Manifestations Typifying Rheumatoid Arthritis
  108. Current Trends in Cancer Nanotheranostics: Metallic, Polymeric, and Lipid-Based Systems
  109. Development of Parvifloron D-loaded Smart Nanoparticles to Target Pancreatic Cancer
  110. α-Galactosylceramide and peptide-based nano-vaccine synergistically induced a strong tumor suppressive effect in melanoma
  111. Track analysis of the passage of rhodamine-labeled liposomes across porcine jejunal mucus in a microchannel device
  112. The role of necroptosis in non-alcoholic fatty liver disease-related carcinogenesis
  113. RIP3-dependent signalling contributes to non-alcoholic fatty liver disease-related hepatocarcinogenesis
  114. miRNA-21 ablation protects against liver injury and necroptosis in cholestasis
  115. Lipid Vesicles for Skin Delivery: Evolution from First Generation
  116. Lipid-Based Nanocarriers for the Treatment of Infected Skin Lesions
  117. Microencapsulated Solid Lipid Nanoparticles as a Hybrid Platform for Pulmonary Antibiotic Delivery
  118. The selective cytotoxicity of new triazene compounds to human melanoma cells
  119. Umbilical cord tissue–derived mesenchymal stromal cells maintain immunomodulatory and angiogenic potencies after cryopreservation and subsequent thawing
  120. Lipid-Based Nanocarriers for Cutaneous Leishmaniais and Buruli Ulcer Management
  121. Activation of necroptosis in human and experimental cholestasis
  122. Nanoformulations of a Potent copper-based Aquaporin Inhibitor With Cytotoxic Effect Against Cancer Cells
  123. Nanoformulations of a Triazene Analogue with Specific Affinity to Human Melanoma
  124. Lipid-Based Nanoformulations of Trifluralin Analogs in the Management ofLeishmania InfantumInfections
  125. Human neonatal mesenchymal stem cell spheroids-conditioned medium accelerates skin regeneration
  126. Targeted delivery of paromomycin in murine infectious diseases through association to nano lipid systems
  127. Three-dimensional spheroid cell culture of umbilical cord tissue-derived mesenchymal stromal cells leads to enhanced paracrine induction of wound healing
  128. In vivo delivery of peptides and Toll-like receptor ligands by mannose-functionalized polymeric nanoparticles induces prophylactic and therapeutic anti-tumor immune responses in a melanoma model
  129. What Makes Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells Superior Immunomodulators When Compared to Bone Marrow Derived Mesenchymal Stromal Cells?
  130. Liposomes versus Lipid Nanoparticles: Comparative Study of Lipid-Based Systems as Oryzalin Carriers for the Treatment of Leishmaniasis
  131. The role of human umbilical cord tissue-derived mesenchymal stromal cells (UCX®) in the treatment of inflammatory arthritis
  132. Targeted Delivery of Transferrin-Conjugated Liposomes to an Orthotopic Model of Lung Cancer in Nude Rats
  133. Synthesis, stability, biochemical and pharmacokinetic properties of a new potent and selective 4-oxo-β-lactam inhibitor of human leukocyte elastase
  134. Generation of liposome aerosols with the Aeroneb Pro and the AeroProbe nebulizers
  135. Atomic Force Microscopy for the Characterization of Proteoliposomes
  136. Synthesis and evaluation of rifabutin analogs against Mycobacterium avium and H37Rv, MDR and NRP Mycobacterium tuberculosis
  137. Inhaled Liposomes–Current Strategies and Future Challenges
  138. Developments on Drug Delivery Systems for the Treatment of Mycobacterial Infections
  139. Rifabutin encapsulated in liposomes exhibits increased therapeutic activity in a model of disseminated tuberculosis
  140. Radiation sterilization of antibiotic liposome formulations: A case study
  141. Enzymosomes with surface-exposed superoxide dismutase: In vivo behaviour and therapeutic activity in a model of adjuvant arthritis
  142. Liposomal Superoxide Dismutases and Their Use in the Treatment of Experimental Arthritis
  143. Design and characterization of enzymosomes with surface-exposed superoxide dismutase
  144. Therapeutic Efficacy of Liposomal Rifabutin in a Mycobacterium avium Model of Infection
  145. Formulation of l-asparaginase-loaded poly(lactide-co-glycolide) nanoparticles: influence of polymer properties on enzyme loading, activity and in vitro release
  146. Biological characterization of L -asparaginase liposomal formulations
  147. Liposomal l-asparaginase: in vitro evaluation